|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2024―Mar―22 |
Reporting of Health Equity Considerations in Vaccine Trials for COVID-19: Comment |
Hinpetch Daungsupawong, Viroj Wiwanitkit |
2 |
[GO] |
2024―Mar―04 |
Reporting of Health Equity Considerations in Vaccine Trials for COVID-19: A Methodological Review |
Roger Kou, Sarah Lopes Sadafi, Rachael Principato, Laura N. Anderson, Romina Brignardello-Petersen, Lawrence Mbuagbaw |
3 |
[GO] |
2024―Feb―02 |
External validation of six COVID-19 prognostic models for predicting mortality risk in older populations in a hospital, primary care, and nursing home setting |
Anum Zahra, Maarten van Smeden, Evertine J. Abbink, Jesse M. van den Berg, Marieke T. Blom, Carline J. van den Dries, Jacobijn Gussekloo, Fenne Wouters, Karlijn J. Joling, René Melis, Simon P. Mooijaart, Jeannette B. Peters, Harmke A. Polinder-Bos, Bas F.M. van Raaij, Brent Appelman, Hannah M. la Roi-Teeuw, Karel G.M. Moons, Kim Luijken |
4 |
[GO] |
2024―Feb―01 |
Estimates of sensitivity and specificity of serological tests for SARS-CoV-2 specific antibodies using a Bayesian latent class model approach |
Joana P. Costa, Paula Meireles, Eleftherios Meletis, Polychronis Kostoulas, Milton Severo |
5 |
[GO] |
2024―Feb―01 |
Using the GRADE Evidence to Decision Framework to reach recommendations together with ethnic minority community organisations: the example of COVID-19 vaccine uptake in the UK |
Shaun Treweek, Miriam Brazzelli, Annette Crosse, Sunil Daga, Talia Isaacs, Ria Sunga |
6 |
[GO] |
2024―Jan―23 |
The reporting completeness and transparency of systematic reviews of prognostic prediction models for COVID-19 was poor: a methodological overview of systematic reviews. |
Persefoni Talimtzi, Antonios Ntolkeras, Georgios Kostopoulos, Konstantinos I. Bougioukas, Eirini Pagkalidou, Andreas Ouranidis, Athanasia Pataka, Anna-Bettina Haidich |
7 |
[GO] |
2024―Jan―17 |
The total effect of ethnicity on COVID-19 outcomes is underestimated when conditioning for comorbidities: Response to Learoyd et al |
Fredi Alexander Diaz-Quijano, Luís Ricardo Santos de Melo |
8 |
[GO] |
2024―Jan―17 |
The complexity of the relationship between ethnicity and Covid-19 outcomes: author’s reply |
Annastazia E. Learoyd, Jennifer Nicholas, Abdel Douiri |
9 |
[GO] |
2023―Dec―09 |
Exploring the use and impact of the Australian living guidelines for the clinical care of people with COVID-19: Where to from here? |
Tanya Millard, Julian H. Elliotta, Sally Greena, Steve McGloughlina, Tari Turnera |
10 |
[GO] |
2023―Dec―08 |
Clinical and methodological implications for research elements in systematic reviews on COVID-19 treatment were often unstructured and underreported - a meta-research study |
W. Siemens, G. Bantle, S. Mahler, J. Nothacker, J. Stadelmaier, E.M. Bitzer, Schmucker C, J.J. Meerpohl |
11 |
[GO] |
2023―Aug―25 |
No evidence of important difference in summary treatment effects between COVID-19 preprints and peer-reviewed publications: a meta-epidemiological study |
Mauricia Davidson, Theodoros Evrenoglou, Carolina Graña, Anna Chaimani, Isabelle Boutron |
12 |
[GO] |
2023―Aug―09 |
Equity issues rarely addressed in the development of COVID-19 formal recommendations and good practice statements: a cross-sectional study |
Omar Dewidar, Mostafa Bondok, Leenah Abdelrazeq, Khadija Aliyeva, Karla Solo, Vivian Welch, Romina Brignardello-Petersen, Joseph L. Mathew, Glen Hazlewood, Kevin Pottie, Lisa Hartling, Dina Sami Khalifa, Stephanie Duda, Maicon Falavigna, Joanne Khabsa, Tamara Lotfi, Jennifer Petkovic, Sarah Elliot, Yuan Chi, Roses Parker, Elizabeth Kristjansson, Alison Riddle, Andrea J. Darzi, Olivia Magwood, Ammar Saad, Gabriel Rada, Ignacio Neumann, Mark Loeb, Ludovic Reveiz, Dominik Mertz, Thomas Piggott, Alexis F. Turgeon, Holger Schünemann, Peter Tugwell |
13 |
[GO] |
2023―Jun―28 |
Revisiting ethnic discrepancies in Covid-19 hospitalised cohorts: a correction for collider bias |
Annastazia E. Learoyd, Jennifer Nicholas, Nicholas Hart, Abdel Douiri |
14 |
[GO] |
2023―May―02 |
Validity of prognostic models of critical COVID-19 is variable. A systematic review with external validation |
Gabriela Cárdenas-Fuentes, Magda Bosch de Basea, Inés Cobo, Isaac Subirana, Mario Ceresa, Ernest Famada, Elena Gimeno-Santos, Laura Delgado-Ortiz, Rosa Faner, María Molina-Molina, Àlvar Agustí, Xavier Muñoz, Oriol Sibila, Joaquim Gea, Judith Garcia-Aymerich |
15 |
[GO] |
2023―Mar―24 |
COVID-19 trials were not more likely to report intent to share individual data than non-COVID-19 trials in ClinicalTrials.gov |
Bruno Ramdjee, Mathilde Husson, David Hajage, Florence Tubach, Candice Estellat, Agnès Dechartres |
16 |
[GO] |
2023―Mar―03 |
Non-drug interventions for reducing SARS-CoV-2 transmission are frequently incompletely reported |
Sharon Sanders, Elizabeth Gibson, Paul Glasziou, Tammy Hoffmann |
17 |
[GO] |
2023―Feb―20 |
Weekly updating of guideline recommendations was feasible: the Australian National COVID-19 Clinical Evidence Taskforce |
Jessie Hewitt, Steve McDonald, Alex Poole, Heath White, Simon Turner, Tari Turner |
18 |
[GO] |
2023―Feb―16 |
Cox regression using a calendar time scale was unbiased in simulations of COVID-19 vaccine effectiveness & safety |
Lars Christian Lund, Henrik Støvring, Anton Pottegård, Morten Andersen, Jesper Hallas |
19 |
[GO] |
2022―Dec―14 |
Minimal reporting improvement after peer review in reports of covid-19 prediction models: systematic review |
Mohammed T. Hudda, Lucinda Archer, Maarten van Smeden, Karel G.M. Moons, Gary S. Collins, Ewout W. Steyerberg, Charlotte Wahlich, Johannes B. Reitsma, Richard D. Riley, Ben Van Calster, Laure Wynants |
20 |
[GO] |
2022―Nov―17 |
NON-INTERVENTIONAL STUDIES IN THE COVID-19 ERA: METHODOLOGICAL CONSIDERATIONS FOR STUDY DESIGN AND ANALYSIS |
Anne M. Butler, Mehmet Burcu, Jennifer B. Christian, Fang Tian, Kathleen M. Andersen, William A. Blumentals, Karen E. Joynt Maddox, G. Caleb Alexander |
21 |
[GO] |
2022―Oct―27 |
Predicting COVID-19 prognosis in the ICU remained challenging: external validation in a multinational regional cohort |
Daniek A.M. Meijs, Sander M.J. van Kuijk, Laure Wynants, Björn Stessel, Jannet Mehagnoul-Schipper, Anisa Hana, Clarissa I.E. Scheeren, Dennis C.J.J. Bergmans, Johannes Bickenbach, Margot Vander Laenen, Luc J.M. Smits, Iwan C.C. van der Horst, Gernot Marx, Dieter Mesotten, Bas C.T. van Bussel, Nanon F.L. Heijnen, Mark M.G. Mulder, Marcel Koelmann, Julia L.M. Bels, Nick Wilmes, Charlotte W.E. Hendriks, Emma B.N.J. Janssen, Micheline C.D.M. Florack, Chahinda Ghossein-Doha, Meta C.E. van der Woude, Laura Bormans-Russell, Noёlla Pierlet, Ben Goethuys, Jonas Bruggen, Gilles Vermeiren, Hendrik Vervloessem, Willem Boer |
22 |
[GO] |
2022―Oct―20 |
Understanding how deferred consent affects patient characteristics and outcome: an exploratory analysis of a clinical trial of prone positioning for COVID-19 |
Michael Colacci, Afsaneh Raissi, Ajay Bhasin, Leora Branfield Day, Melissa Bregger, Travis Carpenter, Lana Castellucci, Angela M. Cheung, Laura Dragoi, Richard Dunbar-Yaffe, Lee Fidler, Rob Fowler, Alexi Gosset, Rachel Hensel, Margaret Herridge, Haseena Hussein, Moira Kapral, Laveena Munshi, Kieran Quinn, Fahad Razak, Bruno Roza da Costa, Christine Soong, Terence Tang, Kevin Venus, Amol Verma, Michael Fralick |
23 |
[GO] |
2022―Oct―18 |
How pragmatic are randomized trials of Remdesivir and Favipiravir for in-hospital treatment of Covid-19: A descriptive methodological review of trial design using the PRECIS-2 framework |
Tanmay Sharma, Intisar Qamar, Merrick Zwarenstein |
24 |
[GO] |
2022―Oct―06 |
The relationship between pragmatism, timing, and study size on impact of treatment trials: a qualitative, hypothesis generating study of systemic corticosteroids for COVID-19 |
Aileen Liang, Katrina Domenica Cirone, Xiaoxiao (Daisy) Deng, Merrick Zwarenstein |
25 |
[GO] |
2022―Oct―06 |
Evidence, values & masks for control of COVID-19: two years later |
Benjamin Djulbegovic, Iztok Hozo, Gordon Guyatt |
26 |
[GO] |
2022―Sep―27 |
Three out of four published systematic reviews on COVID-19 treatments were not registered and one third of those registered were published: a meta-research study |
Waldemar Siemens, Julia Nothacker, Julia Stadelmaier, Jörg J. Meerpohl, Christine Schmucker |
27 |
[GO] |
2022―Aug―18 |
Thromboprophylaxis with standard- vs. flexible-dose heparin for hospitalized COVID-19 patients: a target trial emulation |
Gonzalo Martínez-Alés, Arce Domingo-Relloso, Manuel Quintana-Díaz, Carmen Fernández-Capitán, Miguel A. Hernán |
28 |
[GO] |
2022―Aug―04 |
Systematic reviews of convalescent plasma in COVID-19 continue to be poorly conducted and reported: a systematic review. |
Rebecca Whear, Alison Bethel, Rebecca Abbott, Morwenna Rogers, Noreen Orr, Sean Manzi, Obioha C. Ukoumunne, Ken Stein, Jo Thompson Coon |
29 |
[GO] |
2022―Jul―20 |
Gastrointestinal prophylaxis for COVID-19: An illustration of severe bias arising from inappropriate comparators in observational studies |
Kueiyu Joshua Lin, William B. Feldman, Shirley Wang, Siddhi Pramod Pramod Umarje, Elvira D'Andrea, Helen Tesfaye, Luke E. Zabotka, Jun Liu, Rishi J. Desai |
30 |
[GO] |
2022―Jul―19 |
Resources supporting trustworthy, rapid and equitable evidence synthesis and guideline development: Results from the COVID-19 Evidence Network to support Decision-making (COVID-END) |
Michael McCaul, David Tovey, Taryn Young, Vivian Welch, Omar Dewidar, Mireille Goetghebeur, Tamara Kredo, Andrea C. Tricco, Rebecca Glover, Janice Tufte, Amir Qaseem, Reveiz Ludovic, Rebecca L. Morgan, Per Olav Vandvik, Ivan D. Florez |
31 |
[GO] |
2022―Jul―02 |
HIV suppression was maintained during the COVID-19 pandemic in Malawi: a program-level cohort study |
Thokozani Kalua, Matthias Egger, Andreas Jahn, Tiwonge Chimpandule, Rose Kolola, Nanina Anderegg |
32 |
[GO] |
2022―May―28 |
Toward an observatory of the evolution of clinical trials through phylomemy reconstruction: the COVID-19 vaccines example |
Quentin Lobbé, David Chavalarias, Alexandre Delanoë, Gabriel Ferrand, Sarah Cohen-Boulakia, Philippe Ravaud, Isabelle Boutron |
33 |
[GO] |
2022―May―19 |
COVID-19 L·OVE repository is highly comprehensive and can be used as a single source for COVID-19 studies |
F. Verdugo-Paiva, C. Vergara, C. Ávila, J. Castro, J. Cid, V. Contreras, I. Jara, V. Jiménez, M.H. Lee, M. Muñoz, A.M. Rojas-Gómez, P. Rosón-Rodríguez, K. Serrano-Arévalo, I. Silva-Ruz, J. Vásquez-Laval, P. Zambrano-Achig, G. Zavadzki, G. Rada |
34 |
[GO] |
2022―May―02 |
Artificial intelligence in COVID-19 evidence syntheses was underutilized, but impactful: a methodological study |
Juan R. Tercero-Hidalgo, Khalid S. Khan, Aurora Bueno-Cavanillas, Rodrigo Fernández-López, Juan F. Huete, Carmen Amezcua-Prieto, Javier Zamora, Juan M. Fernández-Luna |
35 |
[GO] |
2022―Apr―30 |
A multistakeholder development process to prioritize and translate COVID-19 health recommendations for patients, caregivers and the public. A case study of the COVID-19 Recommendation Map |
Kevin Pottie, Maureen Smith, Micayla Matthews, Nancy Santesso, Olivia Magwood, Tamara Kredo, Sarah Scott, Kerin Bayliss, Ammar Saad, Rinila Haridas, Nicole Detambel, Ashley Motilall, Yvonne Tan, Sally Steinberg, Justyna Litynska, Bart Dietl, Alfonso Ioiri, Ludovic Reveiz, Vivian Welch, Miloslav Klugar, Lawrence Mbuagbaw, Maria Ximena Rojas, Ivan D. Florez, Tamara Lotfi, Amir Qaseem, Joseph L. Mathew, Elie A. Akl, Peter Tugwell, Holger J. Schünemann |
36 |
[GO] |
2022―Apr―06 |
High-cited favorable studies for COVID-19 treatments ineffective in large trials |
John P.A. Ioannidis |
37 |
[GO] |
2022―Mar―30 |
Using Explicit Thresholds for Benefits and Harms in partially contextualized GRADE Guidelines. Pilot experience from a living COVID-19 guideline |
Ignacio Neumann, Eduardo Quiñelen, Paula Nahuelhual, Pamela Burdiles, Natalia Celedón, Katherine Cerda, Paloma Herrera-Omegna, Patricia Kraemer, Karen Dominguez Cancino, Juan Pablo Valenzuela, Dino Sepúlveda, Gian Paolo Morgano, Elie A. Akl, Holger J. Schünemann |
38 |
[GO] |
2022―Mar―25 |
The currency and completeness of specialized databases of COVID-19 publications |
Robyn Butcher, Margaret Sampson, Rachel J. Couban, James Edward Malin, Sara Loree, Stacy Brody |
39 |
[GO] |
2022―Feb―25 |
COVID-19 scenarios for a long-term strategy under fundamental uncertainty |
Frans Brom, Josta de Hoog, J. André Knottnerus, Ruth Mampuys, Tanja van der Lippe |
40 |
[GO] |
2022―Feb―19 |
Most published systematic reviews of remdesivir for COVID-19 were redundant and lacked currency |
Steve McDonald, Simon Turner, Matthew J Page, Tari Turner |
41 |
[GO] |
2022―Jan―15 |
Evidence suggests that SARS-CoV-2 rapid antigen tests provide benefits for epidemic control - observations from Austrian schools |
Jitka Polechová, Kory D. Johnson, Pavel Payne, Alex Crozier, Mathias Beiglböck, Pavel Plevka, Eva Schernhammer |
42 |
[GO] |
2021―Dec―26 |
A cross sectional study found differential risks for COVID-19 seropositivity amongst health care professionals in Chile |
Marcela Zuñiga, Anne J Lagomarcino, Sergio Muñoz, Alfredo Peña Alonso, María Andrea Rodriguez, Miguel L O'Ryan |
43 |
[GO] |
2021―Dec―18 |
Bias as a source of inconsistency in ivermectin trials for COVID-19: A systematic review. Ivermectin's suggested benefits are mainly based on potentially biased results. |
Ariel Izcovich, Sasha Peiris, Martín Ragusa, Fernando Tortosa, Gabriel Rada, Sylvain Aldighieri, Ludovic Reveiz |
44 |
[GO] |
2021―Dec―14 |
COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices |
Zijun Wang, Hui Liu, Yang Li, Xufei Luo, Nan Yang, Meng Lv, Qi Zhou, Qinyuan Li, Ling Wang, Junxian Zhao, Yunlan Liu, Renfeng Su, Shouyuan Wu, Xiao Liu, Siya Zhao, Qianling Shi, Janne Estill, Xingrong Liu, Wenhong Zhang, Yaolong Chen |
45 |
[GO] |
2021―Nov―28 |
Awareness, Value and Use of the Australian living guidelines for the clinical care of people with COVID-19: An Impact Evaluation |
Tanya Millard, Julian H Elliott, Sally Green, Britta Tendal, Joshua P. Vogel, Sarah Norris, Rhiannon Tate, Tari Turner |
46 |
[GO] |
2021―Nov―14 |
The methodology of a “living” COVID-19 registry development in a clinical context |
Chiara Arienti, Silvia Campagnini, Lorenzo Brambilla, Chiara Fanciullacci, Stefano Giuseppe Lazzarini, Andrea Mannini, Michele Patrini, Maria Chiara Carrozza |
47 |
[GO] |
2021―Nov―14 |
International alliance and AGREE-ment of 71 clinical practice guidelines on the management of critical care patients with COVID-19: a living systematic review |
Yasser S. Amer, Maher A. Titi, Mohammad Wefqy Godah, Hayfaa A. Wahabi, Layal Hneiny, Manal Mohamed Abouelkheir, Muddathir H. Hamad, Ghada Metwally ElGohary, Mohamed Ben Hamouda, Hella Ouertatani, Pamela Velasquez-Salazar, Jorge Acosta-Reyes, Samia M. Alhabib, Samia Ahmed Esmaeil, Zbys Fedorowicz, Ailing Zhang, Zhe Chen, Sarah Jane Lipttrott, Niccolò Frungillo, Amr A. Jamal, Sami A. Almustanyir, Newman Ugochukwu Dieyi, John Powell, Katrina J. Hon, Rasmieh Alzeidan, Majduldeen Azzo, Sara Zambrano-Rico, Paulina Ramirez-Jaramillo, Ivan D. Florez |
48 |
[GO] |
2021―Nov―13 |
Guidelines developed under pressure. The case of the COVID-19 low-quality “rapid” guidelines and potential solutions |
Ivan D. Florez, Yasser Sami Amer, Michael McCaul, John N Lavis, Melissa Brouwers |
49 |
[GO] |
2021―Nov―13 |
Many Trials of Hydroxychloroquine for SARS-CoV-2 Were Redundant and Potentially Unethical: An Analysis of the NIH Clinical Trials Registry |
Vignan Yogendrakumar, Brian Dewar, Michaeline McGuinty, Dar Dowlatshahi, Claire Dyason, Edmond SH Kwok, Tim Ramsay, Hans Lund, Michel Shamy |
50 |
[GO] |
2021―Oct―28 |
Challenges of evidence synthesis during the 2020 COVID pandemic: a scoping review |
Hanan Khalil, Lotfi Tamara, Gabriel Rada, Elie A. Akl |
51 |
[GO] |
2021―Oct―27 |
Change in healthcare during Covid-19 pandemic was assessed through observational designs |
Giovanni Corrao, Anna Cantarutti, Matteo Monzio Compagnoni, Matteo Franchi, Federico Rea |
52 |
[GO] |
2021―Oct―27 |
Estimating total morbidity burden of COVID-19: relative importance of death and disability |
Maia P. Smith |
53 |
[GO] |
2021―Sep―20 |
Secondary electronic sources demonstrated very good sensitivity for identifying studies evaluating interventions for COVID-19. |
O Pierre, C Riveros, S Charpy, I Boutron |
54 |
[GO] |
2021―Sep―12 |
Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: a concept paper |
Claire Iannizzi, Elena Dorando, Jacob Burns, Stephanie Weibel, Clare Dooley, Helen Wakeford, Lise J Estcourt, Nicole Skoetz, Vanessa Piechotta |
55 |
[GO] |
2021―Aug―03 |
Evaluating tests for diagnosing COVID-19 in the absence of a reliable reference standard: pitfalls and potential solutions |
Daniël A. Korevaar, Julie Toubiana, Martin Chalumeau, Matthew D.F. McInnes, Jérémie F. Cohen |
56 |
[GO] |
2021―Jul―18 |
COVID-19 and the Future of Clinical Epidemiology |
Katrina Armstrong, Ralph Horwitz |
57 |
[GO] |
2021―Jul―15 |
Clinical Trials in COVID-19 Management & Prevention: A Meta-epidemiological Study examining |
Kimia Honarmand, Jeremy Penn, Arnav Agarwal, Reed Siemieniuk, Romina Brignardello-Petersen, Jessica J. Bartoszko, Dena Zeraatkar, Thomas Agoritsas, Karen Burns, Shannon M. Fernando, Farid Foroutan, Long Ge, Francois Lamontagne, Mario A. Jimenez-Mora, Srinivas Murthy, Juan Jose Yepes-Nuñez, Per O. Vandvik, Zhikang Ye, Bram Rochwerg |
58 |
[GO] |
2021―Jul―13 |
Ethics of COVID-19 vaccine trials in rapidly changing contexts |
J. André Knottnerus |
59 |
[GO] |
2021―Jul―13 |
Placebo-controlled trials with COVID-19 vaccines: participants first |
Rafael Dal-Ré |
60 |
[GO] |
2021―Jul―03 |
Abstracts for reports of randomised trials of COVID-19 interventions had low quality and high spin |
Dongguang Wang, Lingmin Chen, Lian Wang, Fang Hua, Juan Li, Yuxi Li, Yonggang Zhang, Hong Fan, Weimin Li, Mike Clarke |
61 |
[GO] |
2021―Jun―11 |
ENE-COVID nationwide serosurvey served to characterize asymptomatic infections and to develop a symptom-based risk score to predict COVID-19 |
Beatriz Pérez-Gómez, Roberto Pastor-Barriuso, Mayte Pérez-Olmeda, Miguel A Hernán, Jesús Oteo-Iglesias, Nerea Fernández de Larrea, Aurora Fernández-García, Mariano Martín, Pablo Fernández-Navarro, Israel Cruz, Jose L Sanmartín, Jose León Paniagua, Juan F Muñoz-Montalvo, Faustino Blanco, Raquel Yotti, Marina Pollán |
62 |
[GO] |
2021―Jun―02 |
A systematic review that is "rapid" and "living": a specific answer to the COVID-19 pandemic |
S Negrini, Ceravolo MG, P Côté, C Arienti |
63 |
[GO] |
2021―May―25 |
Randomized COVID-19 vaccination rollout can offer direct real-world evidence |
Lars G. Hemkens, Steven N. Goodman |
64 |
[GO] |
2021―May―25 |
Allocation of Scarce Resources in a Pandemic: Rapid Systematic Review Update of Strategies for Policy Makers |
S Hempel, RV Burke, M Hochman, G Thompson, A Brothers, J Shin, A Motala, J Larkin, M Bolshakova, N Fu, J Ringel |
65 |
[GO] |
2021―May―19 |
Using Preprints in Evidence Synthesis: Commentary on experience during the COVID-19 pandemic |
Barbara Clyne, Kieran A. Walsh, Eamon O'Murchu, Melissa K. Sharp, Laura Comber, Kirsty K O’ Brien, Susan M. Smith, Patricia Harrington, Michelle O'Neill, Conor Teljeur, Máirín Ryan |
66 |
[GO] |
2021―Apr―21 |
COVID-19 and the research scholarship ecosystem: help! |
David Moher |
67 |
[GO] |
2021―Apr―06 |
Getting trustworthy guidelines into the hands of global decision-makers and supporting their consideration of contextual factors for implementation: recommendation mapping of COVID-19 guidelines |
Tamara Lotfi, Adrienne Stevens, Elie A. Akl, Maicon Falavigna, Tamara Kredo, Joseph L. Mathew |
68 |
[GO] |
2021―Mar―27 |
Effect Estimates of COVID-19 Non-Pharmaceutical Interventions are Non-Robust and Highly Model-Dependent |
Vincent Chin, John P.A. Ioannidis, Martin A. Tanner, Sally Cripps |
69 |
[GO] |
2021―Mar―26 |
A meta-research study revealed susceptibility of Covid-19 treatment research to white hat bias: First, do no harm |
Ioannis Bellos |
70 |
[GO] |
2021―Mar―18 |
“NEVER LET A CRISIS GO TO WASTE”: HOW SCIENCE HAS RESPONDED TO THE COVID-19 PANDEMIC |
Peter Tugwell, David Tovey, Carlos A. Cuella-Garcia |
71 |
[GO] |
2021―Mar―18 |
New placebo-controlled Covid-19 vaccine trials are ethically questionable; it's now about comparative effectiveness and availability of registered vaccines |
J. André Knottnerus |
72 |
[GO] |
2021―Mar―09 |
Will COVID-19 result in a giant step backwards for women in academic science? |
Larissa Shamseer, Ivy Bourgeault, Eva Grunfeld, Ainsley Moore, Nazia Peer, Sharon E. Straus, Andrea C. Tricco |
73 |
[GO] |
2021―Mar―07 |
The methodological quality is insufficient in clinical practice guidelines in the context of COVID-19: systematic review |
Tanja A Stamm, Margaret R Andrews, Erika Mosor, Valentin Ritschl, Linda C Li, Jasmin K Ma, Adalberto Campo Arias, Sarah Baker, Nicola W Burton, Mohammad Eghbali, Natalia Fernandez, Ricardo JO Ferreira, Gabriele Gäbler, Souzi Makri, Sandra Mintz, Rikke Helene Moe, Elizabeth Morasso, Susan L Murphy, Simiso Ntuli, Maisa Omara, Miguel Angel Simancas Pallares, Jen Horonieff, Gerald Gartlehner |
74 |
[GO] |
2021―Mar―01 |
Vancouver Coastal Health informed COVID-19 response by applying rapid review methodology: Reply to Tricco. |
Linda Dix-Cooper, Martin Dawes, Mina Park |
75 |
[GO] |
2021―Feb―28 |
Reporting and methodological quality of COVID-19 systematic reviews needs to be improved: an evidence mapping |
Yanfei Li, Liujiao Cao, Ziyao Zhang, Liangying Hou, Yu Qin, Xu Hui, Jing Li, Haitong Zhao, Gecheng Cui, Xudong Cui, Rui Li, Qingling Lin, Xiuxia Li, Kehu Yang |
76 |
[GO] |
2021―Feb―03 |
Double-zero-event studies matter: a re-evaluation of physical distancing, face masks, and eye protection for preventing person-to-person transmission of COVID-19 and its policy impact |
Mengli Xiao, Lifeng Lin, James S. Hodges, Chang Xu, Haitao Chu |
77 |
[GO] |
2020―Dec―07 |
The COVID-19 pandemic and a reflection on the conduction of clinical trials in times of war |
Rafael Leite Pacheco, Ana Luiza Cabrera Martimbianco, Rachel Riera |
78 |
[GO] |
2020―Dec―07 |
Modeling the COVID-19 Pandemic: A Comprehensive Guide of Infectious Disease and Decision-Analytic Models |
Stephen Mac, Sharmistha Mishra, Raphael Ximenes, Kali Barrett, Yasin A. Khan, David Naimark, Beate Sander |
79 |
[GO] |
2020―Dec―01 |
Evidence, values & masks for control of COVID-19 |
Benjamin Djulbegovic, Iztok Hozo, Gordon Guyatt |
80 |
[GO] |
2020―Nov―20 |
COVID-19, health inequities, and methodology’s mission |
J. André Knottnerus, Peter Tugwell |
81 |
[GO] |
2020―Nov―11 |
Weekly updates of national living evidence-based guidelines: Methods for the Australian Living Guidelines for Care of People with COVID-19 |
Britta Tendal, Joshua P. Vogel, Steve McDonald, Sarah Norris, Miranda Cumpston, Heath White, Karin Leder, David Fraile Navarro, Saskia Cheyne, Samantha Chakraborty, Melissa Murano, Tanya Millard, Henriette E. Callesen, Rakibul M. Islam, Julian Elliott, Tari Turner |
82 |
[GO] |
2020―Oct―21 |
Research response to COVID-19 needed better coordination and collaboration: a living mapping of registered trials |
Van Thu Nguyen, Philippe Rivière, Pierre Ripoll, Julien Barnier, Romain Vuillemot, Gabriel Ferrand, Sarah Cohen-Boulkia, Philippe Ravaud, Isabelle Boutron, Solaf Alawadhi, Sihem Amer-Yahia, Camila Ávila, Aïda Bafeta, Julia Baudry, Claudia Bollig, Hillary Bonnet, Isabelle Boutron, Marinette Bouet, Guillaume Cabanac, Anna Chaimani, David Chavalarias, Yaolong Chen, Astrid Chevance, Sarah Cohen-Boulakia, Emmanuel Coquery, Francoise Conil, Mauricia Davidson, Laura De Nale, Declan Devane, Elise Diard, Bastien Doreau, Theodoros Evrenoglou, Alice Fabri, Gilles Feron, Gabriel Ferrand, Leopold Fezeu, Mathilde Fouet, Lina Ghosn El Chall, Carolina Graña, Giacomo Grasselli, François Grolleau, Mohand-Said Hacid, Loubna Haddy, Camilla Hansen, Ameer Hohlfeld, Asbjørn Hróbjartsson, Chantal Julia, Dimitris Mavridis, Joerg J. Meerpohl, Brice Meyer, Nivantha Naidoo, Van Nguyen Thu, Theodora Oikonomidi, Elizabeth Pienaar, Fiona Quirke, Gabriel Rada, Philippe Ravaud, Pierre Ripoll, Carolina Riveros, Philippe Rivière, Marie Sauvant, Christine Schmucker, Farouk Toumani, David Tovey, Romain Vuillemot, Jun Xia, Xuan Yu, Emina Zoletic, Pierre Zweigenbaum |
83 |
[GO] |
2020―Oct―14 |
Access to data from clinical trials in the COVID-19 crisis: open, flexible, and time-sensitive |
Michael Ewers, John P.A. Ioannidis, Nikolaus Plesnila |
84 |
[GO] |
2020―Sep―30 |
The impact of the coronavirus disease of 2019 on research. |
Dr. Najla F. Alsiri, Dr. Meshal A. Alhadhoud, Shea Palmer |
85 |
[GO] |
2020―Sep―23 |
Integrating Travel History via Big Data Analytics Under Universal Healthcare Framework for Disease Control and Prevention in the COVID-19 Pandemic |
Kevin Sheng-Kai Ma, Shin-Yi Tsai |
86 |
[GO] |
2020―Jul―03 |
The Importance of Publishing Non-COVID-19 Research during COVID-19 |
Alexander Chaitoff |
87 |
[GO] |
2020―Jul―03 |
Testing COVID-19 tests faces methodological challenges |
Patrick M. Bossuyt |
88 |
[GO] |
2020―Jul―01 |
Open Synthesis and the coronavirus (COVID-19) pandemic in 2020 |
Neal R. Haddaway, Elie A. Akl, Matthew J. Page, Vivian A. Welch, Ciara Keenan, Tamara Lotfi |
89 |
[GO] |
2020―Jun―30 |
Rapid review methods more challenging during COVID-19: Commentary with a focus on 8 knowledge synthesis steps |
Andrea C. Tricco, Chantelle M. Garritty, Leah Boulos, Craig Lockwood, Michael Wilson, Jessie McGowan, Michael McCaul, Brian Hutton, Fiona Clement, Nicole Mittmann, Declan Devane, Etienne V. Langlois, Ahmed M. Abou-Setta, Catherine Houghton, Claire Glenton, Shannon E. Kelly, Vivian A. Welch, Annie LeBlanc, George A. Wells, Ba’ Pham, Simon Lewin, Sharon E. Straus |
90 |
[GO] |
2020―Jun―27 |
Social Media can have an impact on how we manage and investigate the COVID-19 pandemic |
Carlos Cuello-Garcia, Giordano Pérez-Gaxiola, Ludo van Amelsvoort |
91 |
[GO] |
2020―Jun―12 |
Pandemics and methodological developments in epidemiology history |
Alfredo Morabia |
92 |
[GO] |
2020―Jun―09 |
A framework for identifying and mitigating the equity harms of COVID-19 policy interventions |
Rebecca E. Glover, May CI. van Schalkwyk, Elie A. Akl, Elizabeth Kristjannson, Tamara Lotfi, Jennifer Petkovic, Mark P. Petticrew, Kevin Pottie, Peter Tugwell, Vivian Welch |
93 |
[GO] |
2020―Jun―08 |
A large number of COVID-19 interventional clinical trials were registered soon after the pandemic onset: a descriptive analysis |
Ali A. Nasrallah, Sarah H. Farran, Zainab A. Nasrallah, Mohamad A. Chahrour, Hamza A. Salhab, Mohammad Y. Fares, Hussein H. Khachfe, Elie A. Akl |
94 |
[GO] |
2020―Jun―06 |
Using GRADE in situations of emergencies and urgencies: Certainty in evidence and recommendations matters during the COVID-19 pandemic, now more than ever and no matter what |
Holger J. Schünemann, Nancy Santesso, Gunn E. Vist, Carlos Cuello, Tamara Lotfi, Signe Flottorp, Marina Davoli, Reem Mustafa, Joerg J. Meerpohl, Pablo Alonso-Coello, Elie A. Akl |
95 |
[GO] |
2020―May―25 |
‘One more time’: why replicating some syntheses of evidence relevant to COVID-19 makes sense |
Matthew J. Page, Vivian A. Welch, Neal R. Haddaway, Sathya Karunananthan, Lara J. Maxwell, Peter Tugwell |
96 |
[GO] |
2020―Apr―27 |
Lessons from COVID-19 to future evidence synthesis efforts: first living search strategy and out of date scientific publishing and indexing industry (submitted) |
Farhad Shokraneh, Tony Russell-Rose |
97 |
[GO] |
2020―Apr―23 |
Methodological challenges in studying the COVID-19 pandemic crisis |
J. André Knottnerus, Peter Tugwell |
98 |
[GO] |
2020―Apr―22 |
COVID-19 research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine |
Paul Elias Alexander, Victoria Borg Debono, Manoj J. Mammen, Alfonso Iorio, Komal Aryal, Dianna Deng, Eva Brocard, Waleed Alhazzani |
99 |
[GO] |
2020―Apr―21 |
Reply to letter to the editor ‘Lessons from COVID-19 to Future Evidence Synthesis Efforts: First Living Search Strategy and Out of Date Scientific Publishing and Indexing Industry |
Barbara Nussbaumer-Streit, Irma Klerings, Gerald Gartlehner |